Program completion and glycemic control in a remote patient monitoring program for diabetes management: does gender matter?

[1]  Athena K. Ramos,et al.  Association Between Weight Loss and Glycemic Outcomes: A Post Hoc Analysis of a Remote Patient Monitoring Program for Diabetes Management. , 2020, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

[2]  R. Schwab,et al.  Diabetes Management Through Remote Patient Monitoring: The Importance of Patient Activation and Engagement with the Technology. , 2019, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

[3]  Fernando A. Wilson,et al.  Remote Patient Monitoring and Clinical Outcomes for Postdischarge Patients with Type 2 Diabetes. , 2018, Population health management.

[4]  S. Kjeldsen,et al.  Hypertension and cardiovascular risk: General aspects , 2017, Pharmacological research.

[5]  A. Kautzky-Willer,et al.  Sex and gender differences in therapy of type 2 diabetes. , 2017, Diabetes research and clinical practice.

[6]  F. Mauvais-Jarvis.  Gender differences in glucose homeostasis and diabetes , 2017, Physiology & Behavior.

[7]  V. Mohan,et al.  Type 2 Diabetes: Demystifying the Global Epidemic , 2017, Diabetes.

[8]  JoAnn E Manson,et al.  Consideration of Sex Differences in Medicine to Improve Health Care and Patient Outcomes. , 2016, JAMA.

[9]  Fernando A Wilson,et al.  Does telemedicine improve treatment outcomes for diabetes? A meta-analysis of results from 55 randomized controlled trials. , 2016, Diabetes research and clinical practice.

[10]  G. Pacini,et al.  Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus , 2016, Endocrine reviews.

[11]  Buring,et al.  Cardiovascular Disease in Women: Clinical Perspectives. , 2016, Circulation research.

[12]  K. Malterud,et al.  The impact of gender on the long-term morbidity and mortality of patients with type 2 diabetes receiving structured personal care: a 13 year follow-up study , 2016, Diabetologia.

[13]  Catherine Kim,et al.  Sex-Specific Differential in Risk of Diabetes-Related Macrovascular Outcomes , 2015, Current Diabetes Reports.

[14]  L. Geiss,et al.  Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. , 2015, JAMA.

[15]  M. Schütt,et al.  Gender-specific Effects of Treatment with Lifestyle, Metformin or Sulfonylurea on Glycemic Control and Body Weight: A German Multicenter Analysis on 9 108 Patients. , 2015, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[16]  A. O’Cathain,et al.  Who does not participate in telehealth trials and why? A cross-sectional survey , 2015, Trials.

[17]  M. Langarizadeh,et al.  Managing diabetes mellitus using information technology: a systematic review , 2015, Journal of Diabetes & Metabolic Disorders.

[18]  Yun-kai Zhai,et al.  Clinical- and Cost-effectiveness of Telemedicine in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis , 2014, Medicine.

[19]  M. Alvarsson,et al.  Sex differences in type 2 diabetes: focus on disease course and outcomes , 2014, Diabetes, metabolic syndrome and obesity : targets and therapy.

[20]  A. O’Cathain,et al.  Are People With Chronic Diseases Interested in Using Telehealth? A Cross-Sectional Postal Survey , 2014, Journal of medical Internet research.

[21]  C. Armitage,et al.  Home Telehealth Uptake and Continued Use Among Heart Failure and Chronic Obstructive Pulmonary Disease Patients: a Systematic Review , 2014, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[22]  J. Hiller,et al.  Clinician Acceptance is the Key Factor for Sustainable Telehealth Services , 2014, Qualitative health research.

[23]  ManteuffelMarie,et al.  Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. , 2014 .

[24]  J. McGill,et al.  Effect of gender on treatment outcomes in type 2 diabetes mellitus. , 2013, Diabetes research and clinical practice.

[25]  A. Nicolucci,et al.  Sex Disparities in the Quality of Diabetes Care: Biological and Cultural Factors May Play a Different Role for Different Outcomes , 2013, Diabetes Care.

[26]  D. Ardigò,et al.  Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[27]  Tatjana Rundek,et al.  Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis. , 2012, Archives of internal medicine.

[28]  Liancheng Zhao,et al.  Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy , 2012, Lipids in Health and Disease.

[29]  J. Hibbard,et al.  Why Does Patient Activation Matter? An Examination of the Relationships Between Patient Activation and Health-Related Outcomes , 2012, Journal of General Internal Medicine.

[30]  R. Lemmens‐Gruber,et al.  Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus. , 2010, Gender medicine.

[31]  W. Brannath,et al.  Sex-specific differences in glycemic control and cardiovascular risk factors in older patients with insulin-treated type 2 diabetes mellitus. , 2010, Gender medicine.

[32]  T. Mcconnell,et al.  Gender Differences in Cardiovascular Risk Factors and Risk Perception Among Individuals With Diabetes , 2010, The Diabetes educator.

[33]  J. Hibbard,et al.  How do People with Different Levels of Activation Self-Manage their Chronic Conditions? , 2009, The patient.

[34]  J. Polisena,et al.  Home telehealth for diabetes management: a systematic review and meta‐analysis , 2009, Diabetes, obesity & metabolism.

[35]  K. Malterud,et al.  Gender in medicine — does it matter? , 2009, Scandinavian journal of public health.

[36]  Tom H. F. Broens,et al.  Determinants of successful telemedicine implementations: a literature study , 2007, Journal of telemedicine and telecare.

[37]  J. Manson,et al.  Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study , 2007, Diabetologia.

[38]  E. Ding,et al.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. , 2006, JAMA.

[39]  Mark Woodward,et al.  Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies , 2005, BMJ : British Medical Journal.

[40]  Judith H Hibbard,et al.  Development and testing of a short form of the patient activation measure. , 2005, Health services research.

[41]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[42]  P. Nilsson,et al.  Gender differences in risk factor control and treatment profile in diabetes: a study in 229 Swedish primary health care centres , 2004, Scandinavian journal of primary health care.

[43]  P. Whitten,et al.  Systematic review of studies of patient satisfaction with telemedicine , 2000, BMJ : British Medical Journal.

[44]  W. Kannel,et al.  Menopause and Risk of Cardiovascular Disease: The Framingham Study , 1976 .

[45]  T. Carline,et al.  Gender Differences in Living with Diabetes Mellitus , 2013, Materia socio-medica.